These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 12471127)

  • 1. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H.
    Hellwage J; Jokiranta TS; Friese MA; Wolk TU; Kampen E; Zipfel PF; Meri S
    J Immunol; 2002 Dec; 169(12):6935-44. PubMed ID: 12471127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d.
    Bhattacharjee A; Lehtinen MJ; Kajander T; Goldman A; Jokiranta TS
    Mol Immunol; 2010 May; 47(9):1686-91. PubMed ID: 20378178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Each of the three binding sites on complement factor H interacts with a distinct site on C3b.
    Jokiranta TS; Hellwage J; Koistinen V; Zipfel PF; Meri S
    J Biol Chem; 2000 Sep; 275(36):27657-62. PubMed ID: 10837479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.
    Jokiranta TS; Cheng ZZ; Seeberger H; Jòzsi M; Heinen S; Noris M; Remuzzi G; Ormsby R; Gordon DL; Meri S; Hellwage J; Zipfel PF
    Am J Pathol; 2005 Oct; 167(4):1173-81. PubMed ID: 16192651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.
    Lehtinen MJ; Rops AL; Isenman DE; van der Vlag J; Jokiranta TS
    J Biol Chem; 2009 Jun; 284(23):15650-8. PubMed ID: 19351878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin.
    Hellwage J; Jokiranta TS; Koistinen V; Vaarala O; Meri S; Zipfel PF
    FEBS Lett; 1999 Dec; 462(3):345-52. PubMed ID: 10622723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the second heparin-binding domain in human complement factor H.
    Blackmore TK; Hellwage J; Sadlon TA; Higgs N; Zipfel PF; Ward HM; Gordon DL
    J Immunol; 1998 Apr; 160(7):3342-8. PubMed ID: 9531293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.
    Perkins SJ; Goodship TH
    J Mol Biol; 2002 Feb; 316(2):217-24. PubMed ID: 11851332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of Factor H by Factor H-Related Protein 1 Depends on Sialylation of Host Surfaces.
    Dopler A; Stibitzky S; Hevey R; Mannes M; Guariento M; Höchsmann B; Schrezenmeier H; Ricklin D; Schmidt CQ
    Front Immunol; 2021; 12():615748. PubMed ID: 33732239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
    McRae JL; Duthy TG; Griggs KM; Ormsby RJ; Cowan PJ; Cromer BA; McKinstry WJ; Parker MW; Murphy BF; Gordon DL
    J Immunol; 2005 May; 174(10):6250-6. PubMed ID: 15879123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Binding Properties of Individual Functional Sites of Human Complement Factor H.
    Haque A; Cortes C; Alam MN; Sreedhar M; Ferreira VP; Pangburn MK
    Front Immunol; 2020; 11():1728. PubMed ID: 32849614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of electrostatics on factor H function and related pathologies.
    Kieslich CA; Vazquez H; Goodman GN; López de Victoria A; Morikis D
    J Mol Graph Model; 2011 Aug; 29(8):1047-55. PubMed ID: 21605993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
    Hyvärinen S; Meri S; Jokiranta TS
    Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement.
    Kajander T; Lehtinen MJ; Hyvärinen S; Bhattacharjee A; Leung E; Isenman DE; Meri S; Goldman A; Jokiranta TS
    Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2897-902. PubMed ID: 21285368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions.
    Józsi M; Heinen S; Hartmann A; Ostrowicz CW; Hälbich S; Richter H; Kunert A; Licht C; Saunders RE; Perkins SJ; Zipfel PF; Skerka C
    J Am Soc Nephrol; 2006 Jan; 17(1):170-7. PubMed ID: 16338962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.
    Ferreira VP; Herbert AP; Cortés C; McKee KA; Blaum BS; Esswein ST; Uhrín D; Barlow PN; Pangburn MK; Kavanagh D
    J Immunol; 2009 Jun; 182(11):7009-18. PubMed ID: 19454698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11.
    Jarva H; Jokiranta TS; Hellwage J; Zipfel PF; Meri S
    J Immunol; 1999 Oct; 163(7):3957-62. PubMed ID: 10490997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
    Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J
    Front Immunol; 2021; 12():676662. PubMed ID: 34489931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimeric interactions between complement factor H and its C3d ligand provide new insight on complement regulation.
    Okemefuna AI; Li K; Nan R; Ormsby RJ; Sadlon T; Gordon DL; Perkins SJ
    J Mol Biol; 2009 Aug; 391(1):119-35. PubMed ID: 19505474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15.
    Duthy TG; Ormsby RJ; Giannakis E; Ogunniyi AD; Stroeher UH; Paton JC; Gordon DL
    Infect Immun; 2002 Oct; 70(10):5604-11. PubMed ID: 12228288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.